ALKS vs SHC

ALKS exhibits a weak Piotroski F-Score of 4/9, indicating marginal financial health, and lacks an Altman Z-Score, raising concerns about default risk. Despite a strong Graham Number of $18.80 and intrinsic value estimate of $10.01, the current price of $27.76 trades at a significant premium, especially given deteriorating growth and profitability metrics. The company shows a sharp decline in revenue and earnings (YoY: -10.6% and -67.0%), with recent quarterly earnings missing expectations and negative Q/Q trends. Insider selling activity over the past six months further undermines confidence, despite strong historical earnings surprises. The market appears to be pricing in future recovery, but current fundamentals suggest caution.

SHC presents a conflicted profile with a stable Piotroski F-Score of 4/9 but significant valuation gaps, as the current price of $16.30 far exceeds the Graham Number ($3.6) and Intrinsic Value ($7.97). While the company shows explosive earnings growth (175.4% YoY) and strong operating margins, these are offset by a high Debt/Equity ratio of 3.76 and a bearish technical trend. The stark contrast between bullish analyst targets ($20.50) and aggressive insider selling ($1.28B) suggests a high-risk environment where growth expectations are priced in at a steep premium.